CORNING, N.Y.--(BUSINESS WIRE)--Corning Incorporated (NYSE: GLW) today announced that Emory University purchased the label-free Corning® Epic® System to integrate into its extensive drug discovery program at the Emory Chemical Biology Discovery Center (ECBDC). This technology will enable ECBDC to further develop chemical tools for biological research and drive the discovery of new drug compounds which may lead to new therapeutics for disease.
